Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy.

Liu, Biyu; Wang, Qi; Mei, Tingting; Zheng, Jiasheng; Gao, Wenfeng; Yuan, Chunwang; Li, Kang; Zhang, Yonghong

Liu, Biyu; Wang, Qi; Mei, Tingting; Zheng, Jiasheng; Gao, Wenfeng; Yuan, Chunwang; Li, Kang; Zhang, Yonghong.

Afiliación

Liu B; Research Center For Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Wang Q; Research Center For Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Mei T; Research Center For Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Zheng J; Interventional Therapy Center For Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Gao W; Interventional Therapy Center For Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Yuan C; Interventional Therapy Center For Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Li K; Research Center For Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Zhang Y; Interventional Therapy Center For Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.

Front Oncol ; 13: 1106333, 2023.

Article en En | MEDLINE | ID: mdl-36969054

Palabras clave

HBsAg; hepatocellular carcinoma; interventional therapy; pathology; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google